Article Information
vol. 5 no. 206 206ra138
- Received for publication June 11, 2013
- Accepted for publication September 17, 2013
- .
Author Information
- Julie A. Moreno1,
- Mark Halliday1,
- Colin Molloy1,
- Helois Radford1,
- Nicholas Verity1,
- Jeffrey M. Axten2,
- Catharine A. Ortori3,
- Anne E. Willis1,
- Peter M. Fischer4,
- David A. Barrett3 and
- Giovanna R. Mallucci1,*
- 1MRC Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE1 9HN, UK.
- 2GSK Oncology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA 19426, USA.
- 3Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
- 4Division of Medicinal Chemistry and Structural Biology, School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
- ↵*Corresponding author. E-mail: grm7{at}le.ac.uk